ITGB2 and nephrotic syndrome: In contrast, a previous experimental study of adriamycin-induced nephrotic syndrome showed that the percentage of CD8+ cells expressing CD18 in peripheral blood of rats increased at early stages of the disease (around 14 days) and remained elevated until later stages, around 28 days post-disease induction (51).